title: Convalescent plasma levels of TAFI activation peptide predict death and recurrent vascular events in ischemic stroke survivors.
authors.forename: K
authors.initials: K
authors.lastname: Jood
authors.forename: P
authors.initials: P
authors.lastname: Redfors
authors.forename: A
authors.initials: A
authors.lastname: Gils
authors.forename: C
authors.initials: C
authors.lastname: Blomstrand
authors.forename: P J
authors.initials: PJ
authors.lastname: Declerck
authors.forename: C
authors.initials: C
authors.lastname: Jern
mesh_terms: D015415:Biomarkers / Q000097:blood; D002545:Brain Ischemia / Q000097:blood* / Q000401:mortality*; D025901:Carboxypeptidase B2 / Q000097:blood*; D016022:Case-Control Studies; D003289:Convalescence; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D015999:Multivariate Analysis; D010455:Peptides / Q000097:blood*; D011379:Prognosis; D016016:Proportional Hazards Models; D011446:Prospective Studies; D012008:Recurrence; D018570:Risk Assessment; D012307:Risk Factors; D020521:Stroke / Q000097:blood* / Q000401:mortality*; D013548:Sweden / Q000453:epidemiology; D013997:Time Factors
chemical_list: D015415:Biomarkers; D010455:Peptides; D025901:Carboxypeptidase B2